Current status of mucins in the diagnosis and therapy of cancer

BioFactors

Volumn 35, Issue 6, 2009, Pages 509-527

  Rachagani, Satyanarayana ^a   Torres, Maria P ^a   Moniaux, Nicolas ^b   Batra, Surinder K ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b INSERM   (France)

Author keywords

Cancer diagnosis; Cancer therapy; Mucins

Indexed keywords

MUCIN 1 VACCINE; MUCIN 4 VACCINE; OLIGOSACCHARIDE; UNCLASSIFIED DRUG; VACCINE;

BREAST CANCER; CANCER DIAGNOSIS; CANCER THERAPY; CHROMOSOME STRUCTURE; CLINICAL TRIAL; COLON CARCINOMA; COLORECTAL CANCER; DRUG FORMULATION; EPITHELIUM CELL; GENE LOCATION; GLYCOSYLATION; HUMAN; IMMUNIZATION; KIDNEY CANCER; LUNG CANCER; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN SYNTHESIS; REVIEW; STOMACH CANCER;

EID: 73349125438     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.64     Document Type: Review

References (258)

1. Forstner, J. F. (1978) Intestinal mucins in health and disease. Digestion 17, 234-263.
2. Hollingsworth, M. A. and Swanson, B. J. (2004) Mucins in cancer: protection and control of the cell surface. Nat Rev 4, 45-60.
3. Moniaux, N., Escande, F., Porchet, N., Aubert, J. P., and Batra, S. K. (2001) Structural organization and classification of the human mucin genes. Front Biosci 6, D1192-D1206.
4. Brockhausen, I. (1999) Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta 1473, 67-95.
5. Lamblin, G., Degroote, S., Perini, J. M., Delmotte, P., Scharfman, A., Davril, M., Lo-Guidice, J. M., Houdret, N., Dumur, V., Klein, A., and Rousse, P. (2001) Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis. Glycoconj J 18, 661-684.
6. Carraway, K. L. and Hull, S. R. (1989) O-glycosylation pathway for mucin-type glycoproteins. Bioessays 10, 117-121.
7. Hanisch, F. G. (2001) O-glycosylation of the mucin type. Biol Chem 382, 143-149.
8. Fukuda, M. (1996) Possible roles of tumor-associated carbohydrate antigens. Cancer Res 56, 2237-2244.
9. Fukuda, M. (2002) Roles of mucin-type O-glycans in cell adhesion. Biochim Biophys Acta 1573, 394-405.
10. Satoh, S., Hinoda, Y., Hayashi, T., Burdick, M. D., Imai, K., and Hollingsworth, M. A. (2000) Enhancement of metastatic properties of pancreatic cancer cells by MUC1 gene encoding an anti-adhesion molecule. Int J Cancer 88, 507-518.
11. Wesseling, J., van der Valk, S. W., Vos, H. L., Sonnenberg, A., and Hilkens, J. (1995) Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 129, 255-265
12. Gindzienski, A. and Zwierz, K. (1987) The effect of SDS and 2-mercaptoethanol on the supramolecular structure of human gastric mucus gel. Biochem Med Metab Biol 38, 347-354.
13. Paszkiewicz-Gadek, A., Gindzienski, A., and Porowska, H. (1995) The use of preparative polyacrylamide gel electrophoresis and electroelution for purification of mucus glycoproteins. Anal Biochem 226, 263-267.
14. Corfield, A. P., Myerscough, N., Gough, M., Brockhausen, I., Schauer, R., and Paraskeva, C. (1995) Glycosylation patterns of mucins in colonic disease. Biochem Soc Trans 23, 840-845.
15. Gendler, S. J. and Spicer, A. P. (1995) Epithelial mucin genes. Annu Rev Physiol 57, 607-634.
16. Strous, G. J. and Dekker, J. (1992) Mucin-type glycoproteins. Crit Rev Biochem Mol Biol 27, 57-92.
17. Bobek, L. A., Tsai, H., Biesbrock, A. R., and Levine, M. J. (1993) Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). J Biol Chem 268, 20563-20569.
18. Chaturvedi, P., Singh, A. P., and Batra, S. K. (2008) Structure, evolution, and biology of the MUC4 mucin. FASEB J 22, 966-981.
19. Desseyn, J. L., Guyonnet-Duperat, V., Porchet, N., Aubert, J. P., and Laine, A. (1997) Human mucin gene MUC5B, the 10.7-kb large central exon encodes various alternate subdomains resulting in a superrepeat. Structural evidence for a 11p15.5 gene family. J Biol Chem 272, 3168-3178.
20. Desseyn, J. L., Aubert, J. P., Van, S., I, Porchet, N., and Laine, A. (1997) Genomic organization of the 3' region of the human mucin gene MUC5B. J Biol Chem 272, 16873-16883.
21. Desseyn, J. L., Buisine, M. P., Porchet, N., Aubert, J. P., and Laine, A. (1998) Genomic organization of the human mucin gene MUC5B. cDNA and genomic sequences upstream of the large central exon. J Biol Chem 273, 30157-30164.
22. Gum, J. R., Hicks, J. W., Swallow, D. M., Lagace, R. L., Byrd, J. C., Lamport, D. T., Siddiki, B., and Kim, Y. S. (1990) Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. Biochem Biophys Res Commun 171, 407-415.
23. Gum, J. R., Jr., Hicks, J. W., Toribara, N. W., Siddiki, B., and Kim, Y. S. (1994) Molecular cloning of human intestinal mucin (MUC2) cDNA. Identification of the amino terminus and overall sequence similarity to prepro-von Willebrand factor. J Biol Chem 269, 2440-2446.
24. Itoh, Y., Kamata-Sakurai, M., da-Nagai, K., Nagai, S., Tsuiji, M., Ishii- Schrade, K., Okada, K., Goto, A., Fukayama, M., and Irimura, T. (2008) Identification and expression of human epiglycanin/MUC21: a novel transmembrane mucin. Glycobiology 18, 74-83.
25. Lan, M. S., Batra, S. K., Qi, W. N., Metzgar, R. S., and Hollingsworth, M. A. (1990) Cloning and sequencing of a human pancreatic tumor mucin cDNA. J Biol Chem 265, 15294-15299.
26. Shankar, V., Gilmore, M. S., Elkins, R. C., and Sachdev, G. P. (1994) A novel human airway mucin cDNA encodes a protein with unique tandem-repeat organization. Biochem J 300, 295-298.
27. Toribara, N. W., Roberton, A. M., Ho, S. B., Kuo, W. L., Gum, E., Hicks, J. W., Gum, J. R., Jr., Byrd, J. C., Siddiki, B., and Kim, Y. S. (1993) Human gastric mucin. Identification of a unique species by expression cloning. J Biol Chem 268, 5879-5885.
28. Williams, S. J., Munster, D. J., Quin, R. J., Gotley, D. C., and McGuckin, M. A. (1999) The MUC3 gene encodes a transmembrane mucin and is alternatively spliced. Biochem Biophys Res Commun 261, 83-89.
29. Porchet, N., Dufosse, J., Audie, J. P., Duperat, V. G., Perini, J. M., Nguyen, V. C., Degand, P., and Aubert, J. P. (1991) Structural features of the core proteins of human airway mucins ascertained by cDNA cloning. Am Rev Respir Dis 144, S15-S18.
30. Dufosse, J., Porchet, N., Audie, J. P., Guyonnet, D., V, Laine, A., Van- Seuningen, I., Marrakchi, S., Degand, P., and Aubert, J. P. (1993) Degenerate 87-base-pair tandem repeats create hydrophilic/hydrophobic alternating domains in human mucin peptides mapped to 11p15. Biochem J 293, 329-337.
31. Lapensee, L., Paquette, Y., and Bleau, G. (1997) Allelic polymorphism and chromosomal localization of the human oviductin gene (MUC9). Fertil Steril 68, 702-708.
32. Pigny, P., Guyonnet-Duperat, V., Hill, A. S., Pratt, W. S., Galiegue-Zouitina, S., d'Hooge, M. C., Laine, A., Van-Seuningen, I., Degand, P., Gum, J. R., Kim, Y. S., Swallow, D. M., Aubert, J. P., and Porchet, N. (1996) Human mucin genes assigned to 11p15.5: identification and organization of a cluster of genes. Genomics 38, 340-352.
33. Desseyn, J. L., Buisine, M. P., Porchet, N., Aubert, J. P., Degand, P., and Laine, A. (1998) Evolutionary history of the 11p15 human mucin gene family. J Mol Evol 46, 102-106.
34. Desseyn, J. L., Aubert, J. P., Porchet, N., and Laine, A. (2000) Evolution of the large secreted gel-forming mucins. Mol Biol Evol 17, 1175-1184.
35. Guyonnet Duperat, V., Audie, J. P., Debailleul, V., Laine, A., Buisine, M. P., Galiegue-Zouitina, S., Pigny, P., Degand, P., Aubert, J. P., and Porchet, N. (1995) Characterization of the human mucin gene MUC5AC: a consensus cysteine-rich domain for 11p15 mucin genes? Biochem J 305, 211-219.
36. Gum, J. R., Jr., Hicks, J. W., Toribara, N. W., Rothe, E. M., Lagace, R. E., and Kim, Y. S. (1992) The human MUC2 intestinal mucin has cysteinerich subdomains located both upstream and downstream of its central repetitive region. J Biol Chem 267, 21375-21383.
37. Toribara, N. W., Ho, S. B., Gum, E., Gum, J. R., Jr., Lau, P., and Kim, Y. S. (1997) The carboxyl-terminal sequence of the human secretory mucin, MUC6. Analysis Of the primary amino acid sequence. J Biol Chem 272, 16398-16403.
38. Gum, J. R., Byrd, J. C., Hicks, J. W., Toribara, N. W., Lamport, D. T., and Kim, Y. S. (1989) Molecular cloning of human intestinal mucin cDNAs. Sequence analysis and evidence for genetic polymorphism. J Biol Chem 264, 6480-6487.
39. Toribara, N. W., Gum, J. R., Jr., Culhane, P. J., Lagace, R. E., Hicks, J. W., Petersen, G. M., and Kim, Y. S. (1991) MUC-2 human small intestinal mucin gene structure. Repeated arrays and polymorphism. J Clin Invest 88, 1005-1013.
40. Escande, F., Porchet, N., Bernigaud, A., Petitprez, D., Aubert, J. P., and Buisine, M. P. (2004) The mouse secreted gel-forming mucin gene cluster. Biochim Biophys Acta 1676, 240-250.
41. Tytgat, K. M., Buller, H. A., Opdam, F. J., Kim, Y. S., Einerhand, A. W., and Dekker, J. (1994) Biosynthesis of human colonic mucin: Muc2 is the prominent secretory mucin. Gastroenterology 107, 1352-1363.
42. Blank, M., Klussmann, E., Kruger-Krasagakes, S., Schmitt-Graff, A., Stolte, M., Bornhoeft, G., Stein, H., Xing, P. X., McKenzie, I. F., and Verstijnen, C. P. (1994) Expression of MUC2-mucin in colorectal adenomas and carcinomas of different histological types. Int J Cancer 59, 301-306.
43. Reis, C. A., David, L., Carvalho, F., Mandel, U., de, B. C., Mirgorodskaya, E., Clausen, H., and Sobrinho-Simoes, M. (2000) Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas. J Histochem Cytochem 48, 377-388.
44. Utsunomiya, T., Yonezawa, S., Sakamoto, H., Kitamura, H., Hokita, S., Aiko, T., Tanaka, S., Irimura, T., Kim, Y. S., and Sato, E. (1998) Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients. Clin Cancer Res 4, 2605-2614.
45. Dong, Y., Walsh, M. D., Cummings, M. C., Wright, R. G., Khoo, S. K., Parsons, P. G., and McGuckin, M. A. (1997) Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours. J Pathol 183, 311-317.
46. Audie, J. P., Janin, A., Porchet, N., Copin, M. C., Gosselin, B., and Aubert, J. P. (1993) Expression of human mucin genes in respiratory, digestive, and reproductive tracts ascertained by in situ hybridization. J Histochem Cytochem 41, 1479-1485
47. Vandenhaute, B., Buisine, M. P., Debailleul, V., Clement, B., Moniaux, N., Dieu, M. C., Degand, P., Porchet, N., and Aubert, J. P. (1997) Mucin gene expression in biliary epithelial cells. J Hepatol 27, 1057-1066.
48. Yu, D. F., Chen, Y., Han, J. M., Zhang, H., Chen, X. P., Zou, W. J., Liang, L. Y., Xu, C. C., and Liu, Z. G. (2008) MUC19 expression in human ocular surface and lacrimal gland and its alteration in Sjogren syndrome patients. Exp Eye Res 86, 403-411.
49. Bartman, A. E., Sanderson, S. J., Ewing, S. L., Niehans, G. A., Wiehr, C. L., Evans, M. K., and Ho, S. B. (1999) Aberrant expression of MUC5AC and MUC6 gastric mucin genes in colorectal polyps. Int J Cancer 80, 210-218.
50. Buisine, M. P., Janin, A., Maunoury, V., Audie, J. P., Delescaut, M. P., Copin, M. C., Colombel, J. F., Degand, P., Aubert, J. P., and Porchet, N. (1996) Aberrant expression of a human mucin gene (MUC5AC) in rectosigmoid villous adenoma. Gastroenterology 110, 84-91.
51. Balague, C., Gambus, G., Carrato, C., Porchet, N., Aubert, J. P., Kim, Y. S., and Real, F. X. (1994) Altered expression of MUC2, MUC4, and MUC5 mucin genes in pancreas tissues and cancer cell lines. Gastroenterology 106, 1054-1061.
52. Kim, G. E., Bae, H. I., Park, H. U., Kuan, S. F., Crawley, S. C., Ho, J. J., and Kim, Y. S. (2002) Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas. Gastroenterology 123, 1052-1060.
53. Hughes, O. D., Perkins, A. C., Frier, M., Wastie, M. L., Denton, G., Price, M. R., Denley, H., and Bishop, M. C. (2001) Imaging for staging bladder cancer: a clinical study of intravenous 111indium-labelled anti- MUC1 mucin monoclonal antibody C595. BJU Int 87, 39-46.
54. Temann, U. A., Prasad, B., Gallup, M. W., Basbaum, C., Ho, S. B., Flavell, R. A., and Rankin, J. A. (1997) A novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretion. Am J Respir Cell Mol Biol 16, 471-478.
55. Park, S. Y., Roh, S. J., Kim, Y. N., Kim, S. Z., Park, H. S., Jang, K. Y., Chung, M. J., Kang, M. J., Lee, D. G., and Moon, W. S. (2009) Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact. Oncol Rep 22, 649-657.
56. Kocer, B., Soran, A., Erdogan, S., Karabeyoglu, M., Yildirim, O., Eroglu, A., Bozkurt, B., and Cengiz, O. (2002) Expression of MUC5AC in colorectal carcinoma and relationship with prognosis. Pathol Int 52, 470-477.
57. Kocer, B., McKolanis, J., and Soran, A. (2006) Humoral immune response to MUC5AC in patients with colorectal polyps and colorectal carcinoma. BMC Gastroenterol 6, 4.
58. Thornton, D. J., Khan, N., Mehrotra, R., Howard, M., Veerman, E., Packer, N. H., and Sheehan, J. K. (1999) Salivary mucin MG1 is comprised almost entirely of different glycosylated forms of the MUC5B gene product. Glycobiology 9, 293-302.
59. Sheehan, J. K., Howard, M., Richardson, P. S., Longwill, T., and Thornton, D. J. (1999) Physical characterization of a low-charge glycoform of the MUC5B mucin comprising the gel-phase of an asthmatic respiratory mucous plug. Biochem J 338, 507-513.
60. Sheehan, J. K., Brazeau, C., Kutay, S., Pigeon, H., Kirkham, S., Howard, M., and Thornton, D. J. (2000) Physical characterization of the MUC5AC mucin: a highly oligomeric glycoprotein whether isolated from cell culture or in vivo from respiratory mucous secretions. Biochem J 347 (Pt 1), 37-44.
61. Thornton, D. J., Rousseau, K., and McGuckin, M. A. (2008) Structure and function of the polymeric mucins in airways mucus. Annu Rev Physiol 70, 459-486.
62. Thornton, D. J., Carlstedt, I., Howard, M., Devine, P. L., Price, M. R., and Sheehan, J. K. (1996) Respiratory mucins: identification of core proteins and glycoforms. Biochem J 316, 967-975.
63. Thornton, D. J., Howard, M., Khan, N., and Sheehan, J. K. (1997) Identification of two glycoforms of the MUC5B mucin in human respiratory mucus. Evidence for a cysteine-rich sequence repeated within the molecule. J Biol Chem 272, 9561-9566.
64. Henke, M. O., Renner, A., Huber, R. M., Seeds, M. C., and Rubin, B. K. (2004) MUC5AC and MUC5B Mucins are decreased in cystic fibrosis airway secretions. Am J Respir Cell Mol Biol 31, 86-91.
65. Byrd, J. C., Yan, P., Sternberg, L., Yunker, C. K., Scheiman, J. M., and Bresalier, R. S. (1997) Aberrant expression of gland-type gastric mucin in the surface epithelium of Helicobacter pylori-infected patients. Gastroenterology 113, 455-464.
66. de, B. C., Garrido, M., and Real, F. X. (1995) MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach. Gastroenterology 109, 723-734.
67. Ho, S. B., Shekels, L. L., Toribara, N. W., Kim, Y. S., Lyftogt, C., Cherwitz, D. L., and Niehans, G. A. (1995) Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. Cancer Res 55, 2681-2690.
68. Reis, C. A., David, L., Correa, P., Carneiro, F., de, B. C., Garcia, E., Mandel, U., Clausen, H., and Sobrinho-Simoes, M. (1999) Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 59, 1003-1007.
69. Bartman, A. E., Buisine, M. P., Aubert, J. P., Niehans, G. A., Toribara, N. W., Kim, Y. S., Kelly, E. J., Crabtree, J. E., and Ho, S. B. (1998) The MUC6 secretory mucin gene is expressed in a wide variety of epithelial tissues. J Pathol 186, 398-405.
70. Buisine, M. P., Devisme, L., Degand, P., Dieu, M. C., Gosselin, B., Copin, M. C., Aubert, J. P., and Porchet, N. (2000) Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands. II. Duodenum and liver, gallbladder, and pancreas. J Histochem Cytochem 48, 1667-1676.
71. Owens, S. R., Chiosea, S. I., and Kuan, S. F. (2008) Selective expression of gastric mucin MUC6 in colonic sessile serrated adenoma but not in hyperplastic polyp aids in morphological diagnosis of serrated polyps. Mod Pathol 21, 660-669.
72. Chen, Y., Zhao, Y. H., Kalaslavadi, T. B., Hamati, E., Nehrke, K., Le, A. D., Ann, D. K., and Wu, R. (2004) Genome-wide search and identification of a novel gel-forming mucin MUC19/Muc19 in glandular tissues. Am J Respir Cell Mol Biol 30, 155-165.
73. Kerschner, J. E., Khampang, P., Erbe, C. B., Kolker, A., and Cioffi, J. A. Mucin gene 19 (MUC19) expression and response to inflammatory cytokines in middle ear epithelium. Glycoconj J, in press.
74. Rousseau, K., Kirkham, S., Johnson, L., Fitzpatrick, B., Howard, M., Adams, E. J., Rogers, D. F., Knight, D., Clegg, P., and Thornton, D. J. (2008) Proteomic analysis of polymeric salivary mucins: no evidence for MUC19 in human saliva. Biochem J 413, 545-552.
75. Gururaja, T. L., Ramasubbu, N., Venugopalan, P., Reddy, M. S., Ramalingam, K., and Levine, M. J. (1998) Structural features of the human salivary mucin, MUC7. Glycoconj J 15, 457-467.
76. Bergey, E. J., Cho, M. I., Hammarskjold, M. L., Rekosh, D., Levine, M. J., Blumberg, B. M., and Epstein, L. G. (1993) Aggregation of human immunodeficiency virus type 1 by human salivary secretions. Crit Rev Oral Biol Med 4, 467-474.
77. Bergey, E. J., Cho, M. I., Blumberg, B. M., Hammarskjold, M. L., Rekosh, D., Epstein, L. G., and Levine, M. J. (1994) Interaction of HIV-1 and human salivary mucins. J Acquir Immune Defic Syndr 7, 995-1002.
78. Nagashunmugam, T., Malamud, D., Davis, C., Abrams, W. R., and Friedman, H. M. (1998) Human submandibular saliva inhibits human immunodeficiency virus type 1 infection by displacing envelope glycoprotein gp120 from the virus. J Infect Dis 178, 1635-1641.
79. Liu, B., Rayment, S., Oppenheim, F. G., and Troxler, R. F. (1999) Isolation of human salivary mucin MG2 by a novel method and characterization of its interactions with oral bacteria. Arch Biochem Biophys 364, 286-293.
80. Liu, B., Rayment, S. A., Gyurko, C., Oppenheim, F. G., Offner, G. D., and Troxler, R. F. (2000) The recombinant N-terminal region of human salivary mucin MG2 (MUC7) contains a binding domain for oral Streptococci and exhibits candidacidal activity. Biochem J 345, 557-564.
81. Li, S., Intini, G., and Bobek, L. A. (2006) Modulation of MUC7 mucin expression by exogenous factors in airway cells in vitro and in vivo. Am J Respir Cell Mol Biol 35, 95-102.
82. Jumblatt, M. M., McKenzie, R. W., Steele, P. S., Emberts, C. G., and Jumblatt, J. E. (2003) MUC7 expression in the human lacrimal gland and conjunctiva. Cornea 22, 41-45.
83. Sasaki, M., Nakanuma, Y., Ho, S. B., and Kim, Y. S. (1998) Cholangiocarcinomas arising in cirrhosis and combined hepatocellular- cholangiocellular carcinomas share apomucin profiles. Am J Clin Pathol 109, 302-308.
84. Sharma, P., Dudus, L., Nielsen, P. A., Clausen, H., Yankaskas, J. R., Hollingsworth, M. A., and Engelhardt, J. F. (1998) MUC5B and MUC7 are differentially expressed in mucous and serous cells of submucosal glands in human bronchial airways. Am J Respir Cell Mol Biol 19, 30-37.
85. Zhang, S., Zhang, H. S., Reuter, V. E., Slovin, S. F., Scher, H. I., and Livingston, P. O. (1998) Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers. Clin Cancer Res 4, 295-302.
86. Retz, M., Lehmann, J., Roder, C., Plotz, B., Harder, J., Eggers, J., Pauluschke, J., Kalthoff, H., and Stockle, M. (1998) Differential mucin MUC7 gene expression in invasive bladder carcinoma in contrast to uniform MUC1 and MUC2 gene expression in both normal urothelium and bladder carcinoma. Cancer Res 58, 5662-5666.
87. Kim, C. H., Kim, H. J., Song, K. S., Seong, J. K., Kim, K. S., Lee, J. G., and Yoon, J. H. (2005) MUC8 as a ciliated cell marker in human nasal epithelium. Acta Otolaryngol 125, 76-81.
88. Kerschner, J. E. (2007) Mucin gene expression in human middle ear epithelium. Laryngoscope 117, 1666-1676.
89. Takeuchi, K., Yagawa, M., Ishinaga, H., Kishioka, C., Harada, T., and Majima, Y. (2003) Mucin gene expression in the effusions of otitis media with effusion. Int J Pediatr Otorhinolaryngol 67, 53-58.
90. Seong, J. K., Koo, J. S., Lee, W. J., Kim, H. N., Park, J. Y., Song, K. S., Hong, J. H., and Yoon, J. H. (2002) Upregulation of MUC8 and downregulation of MUC5AC by inflammatory mediators in human nasal polyps and cultured nasal epithelium. Acta Otolaryngol 122, 401-407.
91. Carraway, K. L., Ramsauer, V. P., Haq, B., and Carothers Carraway, C. A. (2003) Cell signaling through membrane mucins. Bioessays 25, 66-71.
92. Gendler, S. J., Lancaster, C. A., Taylor-Papadimitriou, J., Duhig, T., Peat, N., Burchell, J., Pemberton, L., Lalani, E. N., and Wilson, D. (1990) Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem 265, 15286-15293.
93. Ligtenberg, M. J., Vos, H. L., Gennissen, A. M., and Hilkens, J. (1990) Episialin, a carcinoma-associated mucin, is generated by a polymorphic gene encoding splice variants with alternative amino termini. J Biol Chem 265, 5573-5578.
94. Wreschner, D. H., Hareuveni, M., Tsarfaty, I., Smorodinsky, N., Horev, J., Zaretsky, J., Kotkes, P., Weiss, M., Lathe, R., Dion, A. (1990) Human epithelial tumor antigen cDNA sequences. Differential splicing may generate multiple protein forms. Eur J Biochem 189, 463-473.
95. Lancaster, C. A., Peat, N., Duhig, T., Wilson, D., Taylor-Papadimitriou, J., and Gendler, S. J. (1990) Structure and expression of the human polymorphic epithelial mucin gene: an expressed VNTR unit. Biochem Biophys Res Commun 173, 1019-1029.
96. Peat, N., Gendler, S. J., Lalani, N., Duhig, T., and Taylor- Papadimitriou, J. (1992) Tissue-specific expression of a human polymorphic epithelial mucin (MUC1) in transgenic mice. Cancer Res 52, 1954-1960.
97. Siddiqui, J., Abe, M., Hayes, D., Shani, E., Yunis, E., and Kufe, D. (1988) Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen. Proc Natl Acad Sci USA 85, 2320-2323.
98. Swallow, D. M., Gendler, S., Griffiths, B., Kearney, A., Povey, S., Sheer, D., Palmer, R. W., and Taylor-Papadimitriou, J. (1987) The hypervariable gene locus PUM, which codes for the tumour associated epithelial mucins, is located on chromosome 1, within the region 1q21-24. Ann Hum Genet 51, 289-294.
99. Gendler, S., Taylor-Papadimitriou, J., Duhig, T., Rothbard, J., and Burchell, J. (1988) A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J Biol Chem 263, 12820-12823.
100. Gendler, S. J. (2001) MUC1, the renaissance molecule. J Mammary Gland Biol Neoplasia 6, 339-353.
101. Brayman, M., Thathiah, A., and Carson, D. D. (2004) MUC1: a multifunctional cell surface component of reproductive tissue epithelia. Reprod Biol Endocrinol 2, 4.
102. Lee, M. J., Lee, H. S., Kim, W. H., Choi, Y., and Yang, M. (2003) Expression of mucins and cytokeratins in primary carcinomas of the digestive system. Mod Pathol 16, 403-410.
103. Ringel, J. and Lohr, M. (2003) The MUC gene family: their role in diagnosis and early detection of pancreatic cancer. Mol Cancer 2, 9.
104. Buisine, M. P., Devisme, L., Degand, P., Dieu, M. C., Gosselin, B., Copin, M. C., Aubert, J. P., and Porchet, N. (2000) Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands. II. Duodenum and liver, gallbladder, and pancreas. J Histochem Cytochem 48, 1667-1676.
105. Masaki, Y., Oka, M., Ogura, Y., Ueno, T., Nishihara, K., Tangoku, A., Takahashi, M., Yamamoto, M., and Irimura, T. (1999) Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma. Hepatogastroenterology 46, 2240-2245.
106. Terada, T., Ohta, T., Sasaki, M., Nakanuma, Y., and Kim, Y. S. (1996) Expression of MUC apomucins in normal pancreas and pancreatic tumours. J Pathol 180, 160-165.
107. Burdick, M. D., Harris, A., Reid, C. J., Iwamura, T., and Hollingsworth, M. A. (1997) Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines. J Biol Chem 272, 24198-24202.
108. Girling, A., Bartkova, J., Burchell, J., Gendler, S., Gillett, C., and Taylor- Papadimitriou, J. (1989) A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int J Cancer 43, 1072-1076.
109. Ajioka, Y., Allison, L. J., and Jass, J. R. (1996) Significance of MUC1 and MUC2 mucin expression in colorectal cancer. J Clin Pathol 49, 560-564.
110. Zotter, S., Lossnitzer, A., Hageman, P. C., Delemarre, J. F., Hilkens, J., and Hilgers, J. (1987) Immunohistochemical localization of the epithelial marker MAM-6 in invasive malignancies and highly dysplastic adenomas of the large intestine. Lab Invest 57, 193-199.
111. Kim, Y. S., Gum, J., Jr., and Brockhausen, I. (1996) Mucin glycoproteins in neoplasia. Glycoconj J 13, 693-707.
112. Taylor-Papadimitriou, J., Burchell, J. M., Plunkett, T., Graham, R., Correa, I., Miles, D., and Smith, M. (2002) MUC1 and the immunobiology of cancer. J Mammary Gland Biol Neoplasia 7, 209-221.
113. Yin, L., Li, Y., Ren, J., Kuwahara, H., and Kufe, D. (2003) Human MUC1 carcinoma antigen regulates intracellular oxidant levels and the apoptotic response to oxidative stress. J Biol Chem 278, 35458-35464.
114. Hattrup, C. L. and Gendler, S. J. (2008) Structure and function of the cell surface (tethered) mucins. Annu Rev Physiol 70, 431-457.
115. Fox, M. F., Lahbib, F., Pratt, W., Attwood, J., Gum, J., Kim, Y., and Swallow, D. M. (1992) Regional localization of the intestinal mucin gene MUC3 to chromosome 7q22. Ann Hum Genet 56, 281-287.
116. Crawley, S. C., Gum, J. R., Jr., Hicks, J. W., Pratt, W. S., Aubert, J. P., Swallow, D. M., and Kim, Y. S. (1999) Genomic organization and structure of the 3' region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin. Biochem Biophys Res Commun 263, 728-736.
117. Moniaux, N., Nollet, S., Porchet, N., Degand, P., Laine, A., and Aubert, J. P. (1999) Complete sequence of the human mucin MUC4: a putative cell membrane-associated mucin. Biochem J 338, 325-333.
118. Khorrami, A. M., Choudhury, A., Andrianifahanana,M., Varshney, G. C., Bhattacharyya, S. N., Hollingsworth, M. A., Kaufman, B., and Batra, S. K. (2002) Purification and characterization of a human pancreatic adenocarcinoma mucin. J Biochem 131, 21-29.
119. Gross, M. S., Guyonnet-Duperat, V., Porchet, N., Bernheim, A., Aubert, J. P., and Nguyen, V. C. (1992) Mucin 4 (MUC4) gene: regional assignment (3q29) and RFLP analysis. Ann Genet 35, 21-26.
120. Higuchi, T., Orita, T., Nakanishi, S., Katsuya, K., Watanabe, H., Yamasaki, Y., Waga, I., Nanayama, T., Yamamoto, Y., Munger, W., Sun, H. W., Falk, R. J., Jennette, J. C., Alcorta, D. A., Li, H., Yamamoto, T., Saito, Y., and Nakamura, M. (2004) Molecular cloning, genomic structure, and expression analysis of MUC20, a novel mucin protein, up-regulated in injured kidney. J Biol Chem 279, 1968-1979.
121. Escande, F., Lemaitre, L., Moniaux, N., Batra, S. K., Aubert, J. P., and Buisine, M. P. (2002) Genomic organization of MUC4 mucin gene Towards the characterization of splice variants. Eur J Biochem 269, 3637-3644.
122. Gipson, I. K., Hori, Y., and Argueso, P. (2004) Character of ocular surface mucins and their alteration in dry eye disease. Ocul Surf 2, 131-148.
123. Juusola, J. and Ballantyne, J. (2005) Multiplex mRNA profiling for the identification of body fluids. Forensic Sci Int 152, 1-12.
124. Gipson, I. K. (2001) Mucins of the human endocervix. Front Biosci 6, D1245-D1255.
125. Liu, B., Offner, G. D., Nunes, D. P., Oppenheim, F. G., and Troxler, R. F. (1998) MUC4 is a major component of salivary mucin MG1 secreted by the human submandibular gland. Biochem Biophys Res Commun 250, 757-761.
126. Reid, C. J., Gould, S., and Harris, A. (1997) Developmental expression of mucin genes in the human respiratory tract. Am J Respir Cell Mol Biol 17, 592-598.
127. Balague, C., Audie, J. P., Porchet, N., and Real, F. X. (1995) In situ hybridization shows distinct patterns of mucin gene expression in normal, benign, and malignant pancreas tissues. Gastroenterology 109, 953-964.
128. Arul, G. S., Moorghen, M., Myerscough, N., Alderson, D. A., Spicer, R. D., and Corfield, A. P. (2000) Mucin gene expression in Barrett's oesophagus: an in situ hybridisation and immunohistochemical study. Gut 47, 753-761.
129. Buisine, M. P., Desreumaux, P., Debailleul, V., Gambiez, L., Geboes, K., Ectors, N., Delescaut, M. P., Degand, P., Aubert, J. P., Colombel, J. F., and Porchet, N. (1999) Abnormalities in mucin gene expression in Crohn's disease. Inflamm Bowel Dis 5, 24-32.
130. Buisine, M. P., Desreumaux, P., Leteurtre, E., Copin, M. C., Colombel, J. F., Porchet, N., and Aubert, J. P. (2001) Mucin gene expression in intestinal epithelial cells in Crohn's disease. Gut 49, 544-551.
131. Buisine, M. P., Devisme, L., Degand, P., Dieu, M. C., Gosselin, B., Copin, M. C., Aubert, J. P., and Porchet, N. (2000) Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands. II. Duodenum and liver, gallbladder, and pancreas. J Histochem Cytochem 48, 1667-1676.
132. Handra-Luca, A., Lamas, G., Bertrand, J. C., and Fouret, P. (2005) MUC1, MUC2, MUC4, and MUC5AC expression in salivary gland mucoepidermoid carcinoma: diagnostic and prognostic implications. Am J Surg Pathol 29, 881-889.
133. Llinares, K., Escande, F., Aubert, S., Buisine, M. P., de, B. C., Batra, S. K., Gosselin, B., Aubert, J. P., Porchet, N., and Copin, M. C. (2004) Diagnostic value of MUC4 immunostaining in distinguishing epithelial mesothelioma and lung adenocarcinoma. Mod Pathol 17, 150-157.
134. Copin, M. C., Buisine, M. P., Devisme, L., Leroy, X., Escande, F., Gosselin, B., Aubert, J. P., and Porchet, N. (2001) Normal respiratory mucosa, precursor lesions and lung carcinomas: differential expression of human mucin genes. Front Biosci 6, D1264-D1275.
135. Tsutsumida, H., Goto, M., Kitajima, S., Kubota, I., Hirotsu, Y., Wakimoto, J., Batra, S. K., Imai, K., and Yonezawa, S. (2007) MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma. Lung Cancer 55, 195-203.
136. M.Andrianifahanana, Moniaux, N., Schmied, B. M., Ringel, J., Friess, H., Hollingsworth, M. A., Buchler, M. W., Aubert, J. P., and Batra, S. K. (2001) Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. Clin Cancer Res 7, 4033-4040.
137. Swartz, M. J., Batra, S. K., Varshney, G. C., Hollingsworth, M. A., Yeo, C. J., Cameron, J. L., Wilentz, R. E., Hruban, R. H., and Argani, P. (2002) MUC4 expression increases progressively in pancreatic intraepithelial neoplasia. Am J Clin Pathol 117, 791-796.
138. Moniaux, N., Andrianifahanana, M., Brand, R. E., and Batra, S. K. (2004) Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy. Br J Cancer 91, 1633-1638.
139. Chauhan, S. C., Singh, A. P., Ruiz, F., Johansson, S. L., Jain, M., Smith, L. M., Moniaux, N., and Batra, S. K. (2006) Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125). Mod Pathol 19, 1386-1394.
140. Singh, A. P., Chaturvedi, P., and Batra, S. K. (2007) Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy. Cancer Res 67, 433-436.
141. Rakha, E. A., Boyce, R. W., bd El-Rehim, D., Kurien, T., Green, A. R., Paish, E. C., Robertson, J. F., and Ellis, I. O. (2005) Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer. Mod Pathol 18, 1295-1304.
142. Leikauf, G. D., Borchers, M. T., Prows, D. R., and Simpson, L. G. (2002) Mucin apoprotein expression in COPD. Chest 121, 166S-182S.
143. Williams, S. J., McGuckin, M. A., Gotley, D. C., Eyre, H. J., Sutherland, G. R., and Antalis, T. M. (1999) Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res 59, 4083-4089.
144. Packer, L. M., Williams, S. J., Callaghan, S., Gotley, D. C., and McGuckin, M. A. (2004) Expression of the cell surface mucin gene family in adenocarcinomas. Int J Oncol 25, 1119-1126.
145. Williams, S. J., Wreschner, D. H., Tran, M., Eyre, H. J., Sutherland, G. R., and McGuckin, M. A. (2001) Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells. J Biol Chem 276, 18327-18336.
146. Walsh, M. D., Young, J. P., Leggett, B. A., Williams, S. H., Jass, J. R., and McGuckin, M. A. (2007) The MUC13 cell surface mucin is highly expressed by human colorectal carcinomas. Hum Pathol 38, 883-892.
147. Pallesen, L. T., Berglund, L., Rasmussen, L. K., Petersen, T. E., and Rasmussen, J. T. (2002) Isolation and characterization of MUC15, a novel cell membrane-associated mucin. Eur J Biochem 269, 2755-2763.
148. Pallesen, L. T., Pedersen, L. R., Petersen, T. E., Knudsen, C. R., and Rasmussen, J. T. (2008) Characterization of human mucin (MUC15) and identification of ovine and caprine orthologs. J Dairy Sci 91, 4477-4483.
149. Huang, J., Che, M. I., Huang, Y. T., Shyu, M. K., Huang, Y. M., Wu, Y. M., Lin, W. C., Huang, P. H., Liang, J. T., Lee, P. H., and Huang, M. C. (2009) Overexpression of MUC15 activates extracellular signal-regulated kinase 1/2 and promotes the oncogenic potential of human colon cancer cells. Carcinogenesis 30, 1452-1458.
150. Maeda, T., Inoue, M., Koshiba, S., Yabuki, T., Aoki, M., Nunokawa, E., Seki, E., Matsuda, T., Motoda, Y., Kobayashi, A., Hiroyasu, F., Shirouzu, M., Terada, T., Hayami, N., Ishizuka, Y., Shinya, N., Tatsuguchi, A., Yoshida, M., Hirota, H., Matsuo, Y., Tani, K., Arakawa, T., Carninci, P., Kawai, J., Hayashizaki, Y., Kigawa, T., and Yokoyama, S. (2004) Solution structure of the SEA domain from the murine homologue of ovarian cancer antigen CA125 (MUC16). J Biol Chem 279, 13174-13182.
151. O'Brien, T. J., Beard, J. B., Underwood, L. J., and Shigemasa, K. (2002) The CA 125 gene: a newly discovered extension of the glycosylated Nterminal domain doubles the size of this extracellular superstructure. Tumour Biol 23, 154-169.
152. Yin, B. W. and Lloyd, K. O. (2001) Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16. J Biol Chem 276, 27371-27375.
153. Blalock, T. D., Spurr-Michaud, S. J., Tisdale, A. S., Heimer, S. R., Gilmore, M. S., Ramesh, V., and Gipson, I. K. (2007) Functions of MUC16 in corneal epithelial cells. Invest Ophthalmol Vis Sci 48, 4509-4518.
154. Bast, R. C., Jr., Badgwell, D., Lu, Z., Marquez, R., Rosen, D., Liu, J., Baggerly, K. A., Atkinson, E. N., Skates, S., Zhang, Z., Lokshin, A., Menon, U., Jacobs, I., and Lu, K. (2005) New tumor markers: CA125 and beyond. Int J Gynecol Cancer 15 (Suppl 3), 274-281.
155. Williams, S. J., McGuckin, M. A., Gotley, D. C., Eyre, H. J., Sutherland, G. R., and Antalis, T. M. (1999) Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res 59, 4083-4089.
156. Gum, J. R., Jr., Crawley, S. C., Hicks, J. W., Szymkowski, D. E., and Kim, Y. S. (2002) MUC17, a novel membrane-tethered mucin. Biochem Biophys Res Commun 291, 466-475.
157. Van Klinken, B. J., Van Dijken, T. C., Oussoren, E., Buller, H. A., Dekker, J., and Einerhand, A. W. (1997) Molecular cloning of human MUC3 cDNA reveals a novel 59 amino acid tandem repeat region. Biochem Biophys Res Commun 238, 143-148
158. Moniaux, N., Junker, W. M., Singh, A. P., Jones, A. M., and Batra, S. K. (2006) Characterization of human mucin MUC17. Complete coding sequence and organization. J Biol Chem 281, 23676-23685.
159. Malmberg, E. K., Pelaseyed, T., Petersson, A. C., Seidler, U. E., De, J. H., Riordan, J. R., and Hansson, G. C. (2008) The C-terminus of the transmembrane mucin MUC17 binds to the scaffold protein PDZK1 that stably localizes it to the enterocyte apical membrane in the small intestine. Biochem J 410, 283-289.
160. Corrales, R. M., Galarreta, D. J., Herreras, J. M., Calonge, M., and Chaves, F. J. (2003) [Normal human conjunctival epithelium expresses MUC13, MUC15, MUC16 and MUC17 mucin genes]. Arch Soc Esp Oftalmol 78, 375-381.
161. Li, G. S., Zhang, H., Lu, J. C., Hou, P., Zhou, Y., Ma, X. Z., and Wang, H. Y. (2005) [Variable number of tandem repeats polymorphism of MUC20 is associated with the progression of IgA nephropathy]. Zhonghua Yi Xue Za Zhi 85, 1333-1338.
162. Keicho, N., Ohashi, J., Tamiya, G., Nakata, K., Taguchi, Y., Azuma, A., Ohishi, N., Emi, M., Park, M. H., Inoko, H., Tokunaga, K., and Kudoh, S. (2000) Fine localization of a major disease-susceptibility locus for diffuse panbronchiolitis. Am J Hum Genet 66, 501-507.
163. Itoh, Y., Kamata-Sakurai, M., da-Nagai, K., Nagai, S., Tsuiji, M., Ishii-Schrade, K., Okada, K., Goto, A., Fukayama, M., and Irimura, T. (2008) Identification and expression of human epiglycanin/MUC21: a novel transmembrane mucin. Glycobiology 18, 74-83.
164. Devine, P. L. and McKenzie, I. F. (1992) Mucins: structure, function, and associations with malignancy. Bioessays 14, 619-625.
165. Apostolopoulos, V. and McKenzie, I. F. (1994) Cellular mucins: targets for immunotherapy. Crit Rev Immunol 14, 293-309.
166. Kotera, Y., Fontenot, J. D., Pecher, G., Metzgar, R. S., and Finn, O. J. (1994) Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients. Cancer Res 54, 2856-2860.
167. Inufusa, H., Nakatani, Y., Adachi, T., Wakano, T., Nakajima, A., Nakamura, M., Suzuki, M., Ando, O., Kurimoto, M., Miyake, M., Shindo, K., and Yasutomi, M. (1998) Correlation of prognosis of breast cancer patients and expression of Ley which acts as a cofactor of tumor procoagulant. Int J Oncol 13, 481-487.
168. Leivonen, M., Nordling, S., Lundin, J., von, B. K., and Haglund, C. (2001) p27 expression correlates with short-term, but not with longterm prognosis in breast cancer. Breast Cancer Res Treat 67, 15-22.
169. Nakagoe, T., Fukushima, K., Itoyanagi, N., Ikuta, Y., Oka, T., Nagayasu, T., Ayabe, H., Hara, S., Ishikawa, H., and Minami, H. (2002) Expression of ABH/Lewis-related antigens as prognostic factors in patients with breast cancer. J Cancer Res Clin Oncol 128, 257-264.
170. Yamaguchi, A., Ding, K., Maehara, M., Goi, T., and Nakagawara, G. (1998) Expression of nm23-H1 gene and Sialyl Lewis X antigen in breast cancer. Oncology 55, 357-362.
171. Rodriguez de, P. L., Arnaiz, F., Estenoz, J., Ortuno, B., and Lanzos, E. (1995) Study of serum tumor markers CEA CA 15.3 and CA 27.29 as diagnostic parameters in patients with breast carcinoma. Int J Biol Markers 10, 24-29.
172. Correale, M., Abbate, I., Gargano, G., Catino, A., Dragone, C. D., Musci, M. D., Serio, G., Paradiso, A., and De, L. M. (1992) Analytical and clinical evaluation of a new tumor marker in breast cancer: CA 27.29. Int J Biol Markers 7, 43-46.
173. Tewes, M., Aktas, B., Welt, A., Mueller, S., Hauch, S., Kimmig, R., and Kasimir-Bauer, S. (2009) Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies. Breast Cancer Res Treatment 115, 581-590.
174. Dian, D., Janni, W., Kuhn, C., Mayr, D., Karsten, U., Mylonas, I., Friese, K., and Jeschke, U. (2009) Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodies. Onkologie 32, 238-244.
175. Sonora, C., Mazal, D., Berois, N., Buisine, M. P., Ubillos, L., Varangot, M., Barrios, E., Carzoglio, J., Aubert, J. P., and Osinaga, E. (2006) Immunohistochemical analysis of MUC5B apomucin expression in breast cancer and non-malignant breast tissues. J Histochem Cytochem 54, 289-299.
176. Ohuchida, K., Mizumoto, K., Yamada, D., Fujii, K., Ishikawa, N., Konomi, H., Nagai, E., Yamaguchi, K., Tsuneyoshi, M., and Tanaka, M. (2006) Quantitative analysis of MUC1 and MUC5AC mRNA in pancreatic juice for preoperative diagnosis of pancreatic cancer. Int J Cancer 118, 405-411.
177. Xu, M., Real, F. X., Welt, S., Schussler, M. H., Oettgen, H. F., and Old, L. J. (1989) Expression of TAG-72 in normal colon, transitional mucosa, and colon cancer. Int J Cancer 44, 985-989.
178. Duncan, T. J., Watson, N. F., Al-Attar, A. H., Scholefield, J. H., and Durrant, L. G. (2007) The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer. World J Surg Oncol 5, 31.
179. Manne, U., Weiss, H. L., and Grizzle, W. E. (2000) Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas. Clin Cancer Res 6, 4017-4025.
180. Yonezawa, S., Goto, M., Yamada, N., Higashi, M., and Nomoto, M. (2008) Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior. Proteomics 8, 3329-3341.
181. Wang, R. Q. and Fang, D. C. (2003) Alterations of MUC1 and MUC3 expression in gastric carcinoma: relevance to patient clinicopathological features. J Clin Pathol 56, 378-384.
182. Choi, J. S., K.M.A., Lee, H. E., Lee, H. S., and Kim, W. H. (2009) Mucinous gastric carcinomas. Cancer 115, 3581-3590.
183. Reis, C. A., David, L., Nielsen, P. A., Clausen, H., Mirgorodskaya, K., Roepstorff, P., and Sobrinho-Simoes, M. (1997) Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer 74, 112-121.
184. Kocer, B., Soran, A., Kiyak, G., Erdogan, S., Eroglu, A., Bozkurt, B., Solak, C., and Cengiz, O. (2004) Prognostic significance of mucin expression in gastric carcinoma. Dig Dis Sci 49, 954-964.
185. Nakamori, S., Furukawa, H., Hiratsuka, M., Iwanaga, T., Imaoka, S., Ishikawa, O., Kabuto, T., Sasaki, Y., Kameyama, M., Ishiguro, S., and Irimura, T. (1997) Expression of carbohydrate antigen sialyl Le(a): a new functional prognostic factor in gastric cancer. J Clin Oncol 15, 816-825.
186. Mayer, B., Funke, I., and Johnson, J. P. (1996) High expression of a Lewis(x)-related epitope in gastric carcinomas indicates metastatic potential and poor prognosis. Gastroenterology 111, 1433-1446.
187. Guddo, F., Giatromanolaki, A., Koukourakis, M. I., Reina, C., Vignola, A. M., Chlouverakis, G., Hilkens, J., Gatter, K. C., Harris, A. L., and Bonsignore, G. (1998) MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients. J Clin Pathol 51, 667-671
188. Hanaoka, J., Kontani, K., Sawai, S., Ichinose, M., Tezuka, N., Inoue, S., Fujino, S., and Ohkubo, I. (2001) Analysis of MUC4 mucin expression in lung carcinoma cells and its immunogenicity. Cancer 92, 2148-2157.
189. Tsutsumida, H., Goto, M., Kitajima, S., Kubota, I., Hirotsu, Y., Wakimoto, J., Batra, S. K., Imai, K., and Yonezawa, S. (2007) MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma. Lung Cancer (Amsterdam, Netherlands) 55, 195-203.
190. Singh, A. P., Senapati, S., Ponnusamy, M. P., Jain, M., Lele, S. M., Davis, J. S., Remmenga, S., and Batra, S. K. (2008) Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer. Lancet Oncol 9, 1076-1085.
191. Fritsche, H. A. and Bast, R. C. (1998) CA 125 in ovarian cancer: advances and controversy. Clin Chem 44, 1379-1380.
192. Yin, B. W., Dnistrian, A., and Lloyd, K. O. (2002) Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene. Int J Cancer 98, 737-740.
193. Giuntoli, R. L., Rodriguez, G. C., Whitaker, R. S., Dodge, R., and Voynow, J. A. (1998) Mucin gene expression in ovarian cancers. Cancer Res 58, 5546-5550.
194. Skates, S. J., Horick, N., Yu, Y., Xu, F. J., Berchuck, A., Havrilesky, L. J., deBruijn, H. W., van derZee, A. G., Woolas, R. P., Jacobs, I. J., Zhang, Z., and Bast, R. C., Jr. (2004) Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions. J Clin Oncol 22, 4059-4066.
195. Metzgar, R. S., Gaillard, M. T., Levine, S. J., Tuck, F. L., Bossen, E. H., and Borowitz, M. J. (1982) Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Cancer Res 42, 601-608.
196. Mahvi, D. M., Seigler, H. F., Meyers, W. C., Kalthoff, H., Schmiegel, W. H., and Metzgar, R. S. (1988) DU-PAN-2 levels in serum and pancreatic ductal fluids of patients with benign and malignant pancreatic disease. Pancreas 3, 488-493.
197. Metzgar, R. S., Rodriguez, N., Finn, O. J., Lan, M. S., Daasch, V. N., Fernsten, P. D., Meyers, W. C., Sindelar, W. F., Sandler, R. S., and Seigler, H. F. (1984) Detection of a pancreatic cancer-associated antigen (DU-PAN-2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci USA 81, 5242-5246.
198. Sawabu, N., Toya, D., Takemori, Y., Hattori, N., and Fukui, M. (1986) Measurement of a pancreatic cancer-associated antigen (DU-PAN-2) detected by a monoclonal antibody in sera of patients with digestive cancers. Int J Cancer 37, 693-696.
199. Bhargava, A. K., Petrelli, N. J., Karna, A., Parshall, P. L., Fitzpatrick, J. E., Douglass, H. O., Herrera, L., Bray, K., and Gaur, P. (1989) Serum levels of cancer-associated antigen CA-195 in gastrointestinal cancers and its comparison with CA19-9. J Clin Lab Anal 3, 370-377.
200. Magnani, J. L., Steplewski, Z., Koprowski, H., and Ginsburg, V. (1983) Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res 43, 5489-5492.
201. McLaughlin, R., O'Hanlon, D., Kerin, M., Kenny, P., Grimes, H., and Given, H. F. (1999) Are elevated levels of the tumour marker CA19-9 of any clinical significance?--an evaluation. Ir J Med Sci 168, 124-126.
202. Rhodes, J. M. (1999) Usefulness of novel tumour markers. Ann Oncol 10 (Suppl 4), 118-121.
203. Takezako, Y., Okusaka, T., Ueno, H., Ikeda, M., Morizane, C., and Najima, M. (2004) [Tumor markers for pancreatic and biliary tract cancer]. Gan To Kagaku Ryoho 31, 1443-1446.
204. MacLean, G. D., Reddish, M. A., and Longenecker, B. M. (1997) Prognostic significance of preimmunotherapy serum CA27.29 (MUC-1) mucin level after active specific immunotherapy of metastatic adenocarcinoma patients. J Immunother 20, 70-78.
205. Ritts, R. E. and Pitt, H. A. (1998) CA 19-9 in pancreatic cancer. Surg Oncol Clin N Am 7, 93-101.
206. Eskelinen, M. and Haglund, U. (1999) Developments in serologic detection of human pancreatic adenocarcinoma. Scand J Gastroenterol 34, 833-844.
207. Yonezawa, S. and Sato, E. (1997) Expression of mucin antigens in human cancers and its relationship with malignancy potential. Pathol Int 47, 813-830.
208. Choudhury, A., Moniaux, N., Winpenny, J. P., Hollingsworth, M. A., Aubert, J. P., and Batra, S. K. (2000) Human MUC4 mucin cDNA and its variants in pancreatic carcinoma. J Biochem 128, 233-243.
209. Jhala, N., Jhala, D., Vickers, S. M., Eltoum, I., Batra, S. K., Manne, U., Eloubeidi, M., Jones, J. J., and Grizzle, W. E. (2006) Biomarkers in Diagnosis of pancreatic carcinoma in fine-needle aspirates. Am J Clin Pathol 126, 572-579.
210. Gold, D. V., Modrak, D. E., Ying, Z., Cardillo, T. M., Sharkey, R. M., and Goldenberg, D. M. (2006) New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis. J Clin Oncol 24, 252-258.
211. ChakrabortyS., JainM., SassonA. R., and Batra, S. K. (2008) MUC4 as a diagnostic marker in cancer. Exp Opin Med Diagn 2, 891-910.
212. Denardo, S. J., Richman, C. M., Albrecht, H., Burke, P. A., Natarajan, A., Yuan, A., Gregg, J. P., O'Donnell, R. T., and Denardo, G. L. (2005) Enhancement of the therapeutic index: from nonmyeloablative and myeloablative toward pretargeted radioimmunotherapy for metastatic prostate cancer. Clin Cancer Res 11, 7187s-7194s.
213. Walsh, M. D., Hohn, B. G., Thong, W., Devine, P. L., Gardiner, R. A., Samaratunga, M. L., and McGuckin, M. A. (1994) Mucin expression by transitional cell carcinomas of the bladder. Br J Urol 73, 256-262.
214. Tamada, S., Goto, M., Nomoto, M., Nagata, K., Shimizu, T., Tanaka, S., Sakoda, K., Imai, K., and Yonezawa, S. (2002) Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis. Pathol Int 52, 713-723.
215. Anderson, K. S. (2009) Tumor vaccines for breast cancer. Cancer Investig 27, 361-368.
216. Barnd, D. L., Lan, M. S., Metzgar, R. S., and Finn, O. J. (1989) Specific, major histocompatibility complex-unrestricted recognition of tumorassociated mucins by human cytotoxic T cells. Proc Natl Acad Sci USA 86, 7159-7163.
217. Ding, L., Lalani, E. N., Reddish, M., Koganty, R., Wong, T., Samuel, J., Yacyshyn, M. B., Meikle, A., Fung, P. Y., and Taylor-Papadimitriou, J. (1993) Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene. Cancer Immunol Immunother 36, 9-17.
218. Finn, O. J. (2003) Premalignant lesions as targets for cancer vaccines. J Exp Med 198, 1623-1626.
219. Gilewski, T., Adluri, S., Ragupathi, G., Zhang, S., Yao, T. J., Panageas, K., Moynahan, M., Houghton, A., Norton, L., and Livingston, P. O. (2000) Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21. Clin Cancer Res 6, 1693-1701.
220. Goydos, J. S., Elder, E., Whiteside, T. L., Finn, O. J., and Lotze, M. T. (1996) A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma. J Surg Res 63, 298-304.
221. Ho, J. J. (2000) Mucins in the diagnosis and therapy of pancreatic cancer. Curr Pharm Des 6, 1881-1896.
222. Ioannides, C. G., Fisk, B., Jerome, K. R., Irimura, T., Wharton, J. T., and Finn, O. J. (1993) Cytotoxic T cells from ovarian malignant tumors can recognize polymorphic epithelial mucin core peptides. J Immunol 151, 3693-3703.
223. Jerome, K. R., Barnd, D. L., Bendt, K. M., Boyer, C. M., Taylor-Papadimitriou, J., McKenzie, I. F., Bast, R. C., Jr., and Finn, O. J. (1991) Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 51, 2908-2916.
224. Oei, A. L., Moreno, M., Verheijen, R. H., Sweep, F. C., Thomas, C. M., Massuger, L. F., and von Mensdorff-Pouilly, S. (2008) Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer. Int J Cancer 123, 1848-1853.
225. Pecher, G., Haring, A., Kaiser, L., and Thiel, E. (2002) Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial. Cancer Immunol Immunother 51, 669-673.
226. Snijdewint, F. G., von Mensdorff-Pouilly, S., Karuntu-Wanamarta, A. H., Verstraeten, A. A., Livingston, P. O., Hilgers, J., and Kenemans, P. (2001) Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients. Int J Cancer 93, 97-106.
227. Reddish, M., MacLean, G. D., Koganty, R. R., Kan-Mitchell, J., Jones, V., Mitchell, M. S., and Longenecker, B. M. (1998) Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide. Int J Cancer 76, 817-823.
228. Karanikas, V., Hwang, L. A., Pearson, J., Ong, C. S., Apostolopoulos, V., Vaughan, H., Xing, P. X., Jamieson, G., Pietersz, G., Tait, B., Broadbent, R., Thynne, G., and McKenzie, I. F. (1997) Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein. J Clin Investig 100, 2783-2792.
229. Apostolopoulos, V., Pietersz, G. A., Tsibanis, A., Tsikkinis, A., Drakaki, H., Loveland, B. E., Piddlesden, S. J., Plebanski, M., Pouniotis, D. S., Alexis, M. N., McKenzie, I. F., and Vassilaros, S. (2006) Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]. Breast Cancer Res 8, R27.
230. Scholl, S. M., Balloul, J. M., Le Goc, G., Bizouarne, N., Schatz, C., Kieny, M. P., von Mensdorff-Pouilly, S., Vincent-Salomon, A., Deneux, L., Tartour, E., Fridman, W., Pouillart, P., and Acres, B. (2000) Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer. J Immunother 23, 570-580.
231. Brossart, P., Wirths, S., Stuhler, G., Reichardt, V. L., Kanz, L., and Brugger, W. (2000) Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells. Blood 96, 3102-3108.
232. O'Boyle, K. P., Zamore, R., Adluri, S., Cohen, A., Kemeny, N., Welt, S., Lloyd, K. O., Oettgen, H. F., Old, L. J., and Livingston, P. O. (1992) Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn. Cancer Res 52, 5663-5667.
233. Adluri, S., Helling, F., Ogata, S., Zhang, S., Itzkowitz, S. H., Lloyd, K. O., and Livingston, P. O. (1995) Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients. Cancer Immunol Immunother 41, 185-192.
234. Kaufman, H. L., S.Kim-Schulze, Manson, K., DeRaffele, G., Mitcham, J., Seo, K. S., Kim, D. W., and Marshall, J. (2007) Poxvirus-based vaccine therapy for patients with advanced pancreatic cancer. J Trans Med 5, 60.
235. Gulley, J. L., Arlen, P. M., Tsang, K. Y., Yokokawa, J., Palena, C., Poole, D. J., Remondo, C., Cereda, V., Jones, J. L., Pazdur, M. P., Higgins, J. P., Hodge, J. W., Steinberg, S. M., Kotz, H., Dahut, W. L., and Schlom, J. (2008) Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma. Clin Cancer Res 14, 3060-3069.
236. Raez, L. E., Fein, S., and Podack, E. R. (2005) Lung cancer immunotherapy. Clin Med Res 3, 221-228.
237. West, H. J. (2009) Novel targeted agents for lung cancer. Clin Lung Cancer 10 (Suppl 1), S41-S46.
238. Palmer, M., Parker, J., Modi, S., Butts, C., Smylie, M., Meikle, A., Kehoe, M., MacLean, G., and Longenecker, M. (2001) Phase I study of the BLP25 (MUC1 peptide) liposomal vaccine for active specific immunotherapy in stage IIIB/IV non-small-cell lung cancer. Clin Lung Cancer 3, 49-57.
239. Soulieres, D., Murray, N., Maksymiuk, A., Marshall, E., Goss, G., and Butts, C. (2005) A liposomal MUC1 vaccine for treatment of non-small cell lung cancer (NSCLC): differences in QOL assessments for Stage IIIBLR and IV patients. J Clin Oncol 2005 ASCO Meeting Proceedings 23, 7209.
240. Sangha, R. and Butts, C. (2007) L-BLP25: a peptide vaccine strategy in non small cell lung cancer. Clin Cancer Res 13, s4652-s4654.
241. Richards, E. R., Devine, P. L., Quin, R. J., Fontenot, J. D., Ward, B. G., and McGuckin, M. A. (1998) Antibodies reactive with the protein core of MUC1 mucin are present in ovarian cancer patients and healthy women. Cancer Immunol Immunother 46, 245-252.
242. Sabbatini, P. J., Ragupathi, G., Hood, C., Aghajanian, C. A., Juretzka, M., Iasonos, A., Hensley, M. L., Spassova, M. K., Ouerfelli, O., Spriggs, D. R., Tew, W. P., Konner, J., Clausen, H., bu Rustum, N., Dansihefsky, S. J., and Livingston, P. O. (2007) Pilot study of a heptavalent vaccinekeyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer. Clin Cancer Res 13, 4170-4177.
243. Diamantidis, M., Tsapournas, G., Kountouras, J., and Zavos, C. (2008) New aspects of regulatory signaling pathways and novel therapies in pancreatic cancer. Current Mol Med 8, 12-37.
244. Wei, J., Gao, W., Wu, J., Meng, K., Zhang, J., Chen, J., and Miao, Y. (2008) Dendritic cells expressing a combined PADRE/MUC4-derived polyepitope DNA vaccine induce multiple cytotoxic T-cell responses. Cancer Biother Radiopharm 23, 121-128.
245. Li, Y. and Cozzi, P. J. (2007) MUC1 is a promising therapeutic target for prostate cancer therapy. Current Cancer Drug Targets 7, 259-271.
246. Pantuck, A. J., vanOphoven, A., Gitlitz, B. J., Tso, C. L., Acres, B., Squiban, P., Ross, M. E., Belldegrun, A. S., and Figlin, R. A. (2004) Phase I trial of antigen-specific gene therapy using a recombinant vaccinia virus encoding MUC-1 and IL-2 in MUC-1-positive patients with advanced prostate cancer. J Immunother 27, 240-253.
247. North, S. A., Graham, K., Bodnar, D., and Venner, P. (2006) A Pilot Study of the Liposomal MUC1 Vaccine BLP25 in Prostate Specific Antigen Failures After Radical Prostatectomy. J Urol 176, 91-95.
248. Loveland, B. E., Zhao, A., White, S., Gan, H., Hamilton, K., Xing, P. X., Pietersz, G. A., Apostolopoulos, V., Vaughan, H., Karanikas, V., Kyriakou, P., McKenzie, I. F., and Mitchell, P. L. (2006) Mannan-MUC1- pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma. Clin Cancer Res 12, 869-877.
249. Wierecky, J., Muller, M. R., Wirths, S., Halder-Oehler, E., Dorfel, D., Schmidt, S. M., Hantschel, M., Brugger, W., Schroder, S., Horger, M. S., Kanz, L., and Brossart, P. (2006) Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients. Cancer Res 66, 5910-5918.
250. Ferreira, C. S., Cheung, M. C., Missailidis, S., Bisland, S., and Gariepy, J. (2009) Phototoxic aptamers selectively enter and kill epithelial cancer cells. Nucleic Acids Res 37, 866-876.
251. Albrecht, H., Denardo, G. L., and Denardo, S. J. (2007) Development of anti-MUC1 di-scFvs for molecular targeting of epithelial cancers, such as breast and prostate cancers. Q J Nucl Med Mol Imaging 51, 304-313.
252. Epenetos, A. A., Hird, V., Lambert, H., Mason, P., and Coulter, C. (2000) Long term survival of patients with advanced ovarian cancer treated with intraperitoneal radioimmunotherapy. Int J Gynecol Cancer 10, 44-46.
253. Barratt-Boyes, S. M., Vlad, A., and Finn, O. J. (1999) Immunization of chimpanzees with tumor antigen MUC1 mucin tandem repeat peptide elicits both helper and cytotoxic T-cell responses. Clin Cancer Res 5, 1918-1924.
254. Julien, S., Picco, G., Sewell, R., Vercoutter-Edouart, A.S., Tarp, M., Miles, D., Clausen, H., Taylor-Papadimitriou, J., and Burchell, J. M. (2009) Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model. Br J Cancer 100, 1746-1754.
255. Mukherjee, P., Pathangey, L. B., Bradley, J. B., Tinder, T. L., Basu, G. D., Akporiaye, E. T., and Gendler, S. J. (2007) MUC1-specific immune therapy generates a strong anti-tumor response in a MUC1-tolerant colon cancer model. Vaccine 25, 1607-1618.
256. Chen, X., Gao, W., Gambotto, A., and Finn, O. J. (2009) Lentiviral vectors encoding human MUC1-specific, MHC-unrestricted single-chain TCR and a fusion suicide gene: potential for universal and safe cancer immunotherapy. Cancer Immunol Immunother 58, 977-987.
257. Reinartz, S., Hombach, A., Kohler, S., Schlebusch, H., Wallwiener, D., Abken, H., and Wagner, U. (2003) Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer. Cancer Res 63, 3234-3240.
258. Xu, Y., Zhang, L., and Hu, G. (2009) Potential application of alternatively glycosylated serum MUC1 and MUC5AC in gastric cancer diagnosis. Biologicals 37, 18-25.